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An audit of ECT in England 2011-2015:  
Usage, demographics, and adherence to guidelines and legislation 
 
Abstract 
Objectives.  Electroconvulsive therapy (ECT) continues to be used in England, but without 
comprehensive national auditing. Therefore information was gathered on usage, 
demographics, consent, and adherence to the guidelines of the National Institute of Clinical 
Excellence (N.I.C.E.) and to the Mental Health Act. 
Design and Methods.  Freedom of Information Act requests were sent to 56 National Health 
Service Trusts.  
Results.  Thirty two trusts provided some usable data. Only ten were able to report how many 
people received psychological therapy prior to ECT in accordance with N.I.C.E. 
recommendations, with figures ranging from 0% to 100%. The number of people currently 
receiving ECT in England annually is between 2,100 - 2,700, and falling. There was a 12-fold 
difference between the Trusts with the highest and lowest usage rates per capita. Most 
recipients are still women (66%) and over 60 (56%). More than a third (39%) is given 
without consent; with 30% of Trusts not adhering to mental health legislation concerning 
second opinions. At least 44% were not using validated measures of efficacy, and at least 
33% failed to do so for adverse effects. Only four providing any actual data for positive 
outcomes or adverse effects. None provided any data on efficacy beyond the end of 
treatment. 
Conclusions.  National audits should be reinstated. Independent, objective monitoring of 
adverse effects is urgently required. An investigation into why ECT is still administered 
excessively to older people and women seems long overdue. 
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Practitioner Points: 
• Mental health staff should seek to ensure that all depressed people in their service are 
offered evidence-based psychological treatments before being offered E.C.T. 
• Staff should lobby managers to ensure proper auditing of E.C.T. within their service 
• Individuals receiving ECT should be closely monitored for adverse cognitive effects 
• Overuse of ECT with women and older people should be avoided 
 
Keywords: Electroconvulsive therapy, auditing, psychological therapy, women, older 
people, consent, mental health legislation 
 
Introduction 
Although the use of ECT in England, and internationally, has been steadily declining for 
decades, mapping that decline accurately has been difficult since the Department of Health   
stopped publishing its national audits of the 1980s and 1990s. Electroconvulsive therapy is 
still used, on several hundred thousand people internationally every year (Leikne et al., 2009; 
Read, Bentall, Johnstone, Fosse, & Bracken, 2013). A review, of 70 studies, found ‘large 
variation between continent, countries and regions in utilization, rates and clinical practice’ 
(Leikne et al. 2012, p. 296). High users include Australia, Belgium, Norway, Sweden and the 
U.S.A. Financial arrangements also vary. In the UK the vast majority of ECT is administered 
within the publicly funded National Health Service (Buley, Hodge & Hailey, 2016), whereas 
in other countries, including the USA and Australia for example, private psychiatrists play a 
leading role.                                                                                             
ECT remains one of the most controversial of psychiatric treatments. Several meta-
analyses conclude it is an effective treatment for depression (Gabor & Laszio, 2005; 
Greenhalgh et al., 2005; Kho et al., 2003; Pagnin et al., 2004; UK ECT Review Group, 2003; 
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van der Wurff et al., 2003). A 2010 review, however, noted that none of these meta-analyses 
identified any evidence that ECT had any benefit, compared to placebo, beyond the end of 
treatment, and that there is no evidence that ECT prevents suicide (Read & Bentall, 2010). 
The most recent review also failed to find a single study showing that ECT is superior to 
placebo beyond the end of treatment (Read & Arnold, 2017). The National Institute of Care 
and Excellence (N.I.C.E.) (2009) has stated that ‘Further research is urgently required to 
examine the long-term efficacy and safety of ECT’. Other reviews (Rasmussen, 2009; Ross, 
2006) had reached similar conclusions to the 2010 review, such as ‘Rigorously defined 
endogenously depressed patients did exceptionally well with sham ECT, as well as with real 
ECT’ (Rasmussen, p.59). The controversy also focuses on the extent to which ECT causes 
long-lasting memory dysfunction, and increases mortality (Breggin, 2008; Fosse & Read, 
2009; Read et al., 2013; Rose et al., 2003, 2004; Sackeim, 2007). 
The controversy includes the issues of when ECT should be used, and on whom. Some 
consider it the treatment of choice for several disorders. Others argue it should never be used. 
A common position is that it should be used only as a last resort, and only when other 
treatments have failed. The UK government guidelines (National Institute for Clinical 
Excellence 2009, 2017) promotes this position. N.I.C.E.  guidelines (2017) currently state:  
 
Consider ECT for acute treatment of severe depression that is life-threatening and 
when a rapid response is required, or when other treatments have failed.  
Do not use ECT routinely for people with moderate depression but consider it if their 
depression has not responded to multiple drug treatments and psychological 
treatment. 
 
This is repeated, almost verbatim by the UK’s Royal College of Psychiatry (2017). 
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Controversy is also to be found about why ECT has consistently been targeted at women  
and older people, internationally, and whether the frequent use of compulsion is ethical or  
evidence-based (Breggin, 2008; Read et al., 2013). In England the Mental Health Act 2007 
revised the legislation relating to treatment without consent (s58A), introducing additional 
safeguards, and guidelines to Second Opinion Appointed Doctors (SOADs) (Department of 
Health, 2009). These safeguards include the requirement that when detained patients are 
deemed incapable of giving consent the SOAD must testify that it is appropriate for the 
patient to receive ECT. Prior to this the SOAD must consult two other persons, one of which 
must be ‘a nurse concerned with the patient’s medical treatment’ and the second ‘another 
person professionally concerned with the patient’s medical treatment who is neither a nurse 
nor a doctor’.  
N.I.C.E. guidelines (2017) also state: 
 
Clinical status should be assessed following each ECT session and treatment should 
be stopped when a response has been achieved, or sooner if there is evidence of 
adverse effects. 
 
This study, therefore, aimed to assess: 
• whether N.I.C.E. guidelines about psychological treatments being tried before ECT, and 
about monitoring negative and positive outcomes, are being followed. 
• whether usage is increasing, decreasing or remaining steady 
• whether the treatment continues to be disproportionately used on women and old people 
•  how much compulsion is being used, and whether legislation regarding Second Opinion 
Appointed Doctors (SOADs) is being complied with 
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Method 
These research questions were addressed using a cross sectional, retrospective design targeted 
at all publicly funded ECT providers in England, addressing ECT usage during 2011, 2013 
and 2015. These years were selected so as to assess both recent practice and recent change 
over time, while maximising the probability of the Trusts being able to provide data. Ethical 
approval was not required as there was no interaction with patients.  
 
Data gathering 
In November 2016, a Freedom of Information (FOI) Act request was sent to the Freedom of  
Information Officer of all 60 publicly funded providers of mental health services in England,  
including 56 National Health Service [NHS] Trusts. The Act entitles anyone to request 
information from any public sector body.  Our request consisted of the following questions, 
developed specifically for this study to address our research questions: 
 
1. For each of the years 2011, 2013 and 2015, how many patients received ECT (Please 
break down the three answers in this section for males/females) 
a) How many of these were under 18? 
b) How many of these were over 60? 
2. For each of the years 2011, 2013 and 2015, what were the documented primary 
diagnoses when given ECT? Depression;  Psychosis; Anxiety Disorder; Personality 
Disorder; Other 
3. For each of the years 2011, 2013 and 2015, how many patients were given ECT 
without consent? 
4. Currently when a patient does not consent what professions does the SOAD consult? 
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5. How many people had ECT in 2015 without receiving a N.I.C.E.  recommended 
psychological therapy? 
6. In 2015 what were the measures used, and results for, in relation to a) Clinical 
outcomes for ECT; b) Adverse effects of ECT. 
 
Participants 
None of the four non-NHS providers provided data, with three explaining they were not 
obliged to do so because they were ‘not a public authority’ and one failing to respond at all. 
Thirty two of the 56 NHS Trusts (57.1%) provided some usable data. The number replying to 
specific questions ranged from 32 (2015 ECT totals) to four (outcome data).  
 
Data analysis 
Being essentially an audit, most of the data is presented in descriptive format. The exceptions  
were the use of two-tailed t-tests to determine if the means of the annual totals differ, and  
Spearman Rank correlation coefficients to assess the stability of differential usage of ECT by  
the various Trusts over time. 
 
Results 
Psychological therapy 
Only ten Trusts answered ‘How many people had ECT without receiving a N.I.C.E.  
recommended psychological therapy in 2015?’ Seven offered no explanation for not 
answering. The other 15 used one or more of the following explanations: ‘not recorded’ (7); 
recorded but not collated - so not easily accessible (5); beyond the amount of information that 
can reasonably be expected to be provided without charging a fee (Section 12 of the FOI Act) 
(6). 
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The ten Trusts reported that 210 of 767 people (27.4%) received ECT without first 
receiving psychological therapy (see Table 1). The range was from 100% in two Trusts 
(Humber, South Staffordshire & Shropshire) to 0% in four (Camden, Hertfordshire, Kent & 
Medway, West London).                                                     
 
INSERT TABLE 1 ABOUT HERE 
 
Numbers  
Twenty nine Trusts provided the number of people given ECT for 2011, 2013 and 2015. 
The three others only provided data for 2015. The total number was 4,536, producing an 
average of 50.40 people per Trust per year. The range was from four (Black Country in 2011) 
to 142 (Cheshire & Wirral in 2011), a 35 fold difference. The range across all 32 Trusts for 
the most recent year (2015) was from eight (West London) to 121 (Surrey & Borders), a 15-
fold difference. Among the 29 providing data for all three years the average per year ranged 
from 8.0 (Black Country) to 126.7 (Surrey & Borders), also a 15-fold difference.  
Table 1 presents the same data in relation to the sizes of the populations served by the 
Trusts. The average number of people receiving ECT across the three years, per 100,000 of 
the total population of each Trust, ranged from 1.03 (Black Country) to 12.70 (North 
Staffordshire), a 12-fold difference. Two other Trusts had rates above 10/100,000: 
Worcestershire (12.38) and Cheshire & Wirral (12.23). Four other Trusts had rates less than 
2.5/100,000: Camden & Islington (2.26); Kent & Medway (2.08); West London (2.05) and 
South West London & St George’s (1.2). 
The average number of ECT recipients per Trust for the three years (n = 29) were: 2011 - 
48.72; 2013 - 54.37; 2015 - 47.76. None of the differences between the three pairs of means 
were significantly different.  
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The pattern of differences between Trusts remained stable over time. Spearman rank 
correlation coefficients between the three pairs of years were: 2011 - 2013 = 0.90; 2013 - 
2015 = 0.89; 2011 - 2015 = 0.87; these were all significant at the p < .0001 level. 
 
Gender and age 
Twenty eight Trusts provided gender data, for 3,901 people. Of these, 2,579 (66.1%) were  
women. The range was from 48.8% (West London) to 85.7% (South Staffordshire &  
Shropshire). In 25 of the 28 Trusts (89%) more than 55% were women. In fifteen (54%)  
women were at least twice as likely to receive ECT as men (< 66.7%). Women in Oxford  
were three times more likely than men to receive ECT (75.1%); and six times more likely in  
South Staffordshire & Shropshire.  
Twenty nine Trusts answered the age-related questions. Of 3,925 ECT recipients, 2,216 
(56.5%)  were over 60. Table 1 shows that the lowest rates were in Camden (22.2%) and 
Greater Manchester (31.0%), and the highest in South Staffordshire & Shropshire (82.1%), 
Barnet, Enfield & Haringey (75.5%) and Birmingham & Solihull (73.5%). In 21 out of 29 
Trusts (72%) at least half of ECT recipients were aged over 60.  
Only 0.2% of ECT recipients were children, i.e. aged under 18. Only five Trusts had 
used ECT on children in any of the three years. The highest rate across the three years was in 
Birmingham & Solihull (2.6%, 4 out of 155). 
 
Diagnoses 
Data on 2,564 people, from 22 Trusts, showed that most people were diagnosed with 
Depression (2,186; 85.3%). The range was from 35.0% (Black Country) and 40.5% (South 
Staffordshire & Shropshire) to 100% for three Trusts (Coventry & Warwickshire, Dorset, and 
West London). Other diagnostic groupings were: Psychosis (135, 5.3%); Bipolar/Mania (51, 
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2.0%); Personality Disorder (39, 1.5%), Anxiety (18, 0.7%), and Dementia (3, 0.1%). Twelve 
of the 22 Trusts (54%) administered ECT to at least one person with a primary diagnosis for 
which ECT is not indicated (Anxiety - 7 Trusts; Personality Disorder - 6; Dementia - 1). In 
South Staffordshire & Shropshire, 23 of 84 ECT recipients (27.4%) were diagnosed with 
Personality Disorder.  
 
Consent 
Data on 2,987 people, from 22 Trusts, indicated that 1,157 (38.7%) had been given ECT 
without their consent. Table 1 shows that this ranged from 15.3% (Surrey & Borders) to 
72.2% (Hertfordshire) and 100% (Black Country). 
Professions used by Second Opinion Appointed Doctors, to certify ECT in the case of 
people deemed to lack capacity to give consent were: OTs (80%); nurses (65%); 
physiotherapists (45%); clinical psychologists (30%); pharmacists (30%); doctors (15%); 
social workers (15%); dieticians (5%); and ward managers (5%). Fourteen out of the 20 
Trusts that provided this data (70%) were using the combination of professionals required by 
the Mental Health Act.  
  
Efficacy 
Methods.  Nine Trusts (28%) provided no information about the measures they used in  
relation to clinical outcomes.  The most commonly used, by 16 of the 23 (70%) that did 
provide information was the Clinical Global Impressions (CGI) scale, in which a single 
clinician subjectively assesses severity of psychopathology, and change from start of 
treatment, on seven-point scales. Table 1 shows that 13 of the 23 Trusts (56.5%) used one or 
more of the following validated scales (see Table 1):  Mini Mental State Examination 
[MMSE] (5 Trusts); Montgomery-Åsberg Depression Rating Scale (4); Hamilton Depression 
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Rating Scale (3); Hospital Anxiety and Depression Scale (1); Health of the Nation Scale (1); 
Beck Depression Inventory (1). Six used only the subjective CGI scale. The other four 
described a range of other subjective approaches to assessing efficacy, such as ‘ward 
observations’ and ‘psychiatrist review’.  
     Measures and assessments were administered regularly during treatment, but no Trusts 
mentioned any follow up assessments after the end of treatment. None referred to any 
independent assessments, at any time by anyone not involved in delivering ECT.  
 
Data.  Only four of the 33 Trusts (12.1%) provided any actual data about clinical outcomes. 
Two provided some data from the seven point CGI scale (anchor points ‘significantly 
improved’ and significantly worse’). Cornwall reported findings for after each individual 
administration of ECT rather than for each patient. Their findings, for 310 administrations (an 
average of ten per person) were: Significantly improved - 21 (6.8%); Much improved - 96 
(31.0%); Minimally improved - 96 (31.0%); No change - 81(26.1%); Minimally worse - 7 
(2.3%); Much worse - 2 (0.6%); Significantly worse - 1 (0.3); and six not assessed. Coventry 
& Warwickshire, reporting on people rather than individual treatments, wrote: ‘100% CGI 6 
or 7 prior to trt (severely ill/amongst the most severely ill). 95% CGI score of 1, 2 or 3 post 
course (Very much improved, much improved, improved). 5% 4 no change’.   
     Coventry & Warwickshire also reported that ‘All Hospital Anxiety and Depression Scale 
scores improved at end of course to varying degrees’. Greater Manchester West, who had 
used the CGI and the Montgomery-Åsberg Depression Rating Scale, simply reported that ‘all 
patients reported improvement with ECT’. Surrey & Borders, who had provided no 
information about how efficacy had been measured, stated ‘80-90% improvement’. No 
follow up data, beyond the end of treatment, was reported by any Trusts. 
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Adverse effects 
Measures.  Eleven Trusts failed to provide any information about what measures of adverse 
effects were used. Of the 21 providing information, 14 reported using one or more validated 
scale, most commonly the MMSE (8) and the Montreal Cognitive Assessment Measure (5). 
Two used the Addenbrookes Cognitive Examination, and two used the Six-item Cognitive 
Impairment Test [6CIT]. The other seven Trusts offered more general comments such as 
‘short term memory is monitored along with physical health assessment’. Measures and 
assessments were administered regularly during treatment.  
Four Trusts mentioned assessment beyond the end of treatment. Only three Trusts 
included information about who did the assessing: ‘Patient's own views and their treating 
clinician's assessment’, ‘Consultant reviews’ and ‘Subjective questions, gathering the 
opinions of staff, carers, relatives’. None referred to any assessments by anyone not directly 
involved.  
 
Data.  Only four Trusts provided actual data on adverse effects. Coventry & Warwickshire 
reported that of their 54 ECT recipients ‘4.9% scored above 24 using MMSE post treatment 
(normal range)’, indicating that 95.1% had mild, moderate or severe cognitive impairment 
following ECT. Greater Manchester West reported that of their 40 ECT patients, ‘6 short 
term memory loss (resolved after 2-3 days); seven patients had headaches post ECT resolved 
with analgesics’. 
     Surrey and Borders reported that their 121 patients experienced only ‘headaches’ and 
‘nausea’. Leicestershire, with 47 ECT recipients, stated ‘there were no adverse effects of ECT 
on any patient in 2015’. No Trusts reported any follow up data beyond the end of treatment.   
      
Discussion 
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Psychological therapy 
Unfortunately the data gathered in the current study cannot reliably answer the question 
‘How many people had ECT without receiving a N.I.C.E recommended psychological 
therapy?’ because only ten of 32 (31%) responded to this question. This represents just 18% 
of the 56 Trusts that were asked the question. Failure to record or collate this information 
suggests that most Trusts are not interested in, or aware of, N.I.C.E guidelines on this matter. 
The fact that in at least two Trusts ECT was given to everyone (158 in total) without any of 
them having first received psychological therapy is a flagrant breach of N.I.C.E guidelines. It 
seems some clinicians remain unconvinced of the need for an integrated, evidence-based 
approach involving the non-medical treatments recommended by N.I.C.E. 
N.I.C.E. supports its recommendations for the use of psychological treatments for  
depression with a range of studies and reviews, including a meta-analysis that examined 17 
randomized control trials involving over 3000 participants and found an overall benefit of 
psychological therapies compared with usual care, particularly for CBT-type interventions 
(van t’Hof, Cuijpers, Waheed, & Stein, 2011). Unlike ECT, psychological treatments can 
teach new techniques which last beyond the end of treatment and which may contribute to 
self help and early recognition and intervention. Psychological treatments involve active 
involvement rather than the passive role of a ‘patient’ receiving a ‘treatment’ and, hopefully, 
a collaborative relationship of the kind clients might need to prevent or overcome further 
‘episodes’. Furthermore E.C.T. cannot address the various well documented psycho-social 
causes of depression such as loss, neglect and abuse (Cromby, Harper & Reavey, 2013; 
Kendler, Hettema, Butera, Gardner, & Prescott, 2003). One additional reason why there is so 
much evidence for the efficacy of psycho-social interventions and so little for E.C.T. relates 
to the implied messages about causation that accompany the treatments. Assumptions that 
one’s difficulties are caused by their being something wrong with one’s brain are associated 
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not only with greater prejudice from other people, but with pessimism about recovery and 
less effort to improve one’s own situation (Kvaale, Haslam, Gottdiener, 2013; Read, Haslam, 
Sayce, & Davies, 2006). 
 
Numbers 
     A comprehensive survey by the Royal College of Psychiatrists (RCP) estimated that 
27,000 people received ECT in Great Britain in 1980, and that usage had halved since the 
early 1970s (Pippard & Ellam, 1981). Department of Health reports for England (1989, 1999) 
show that the number of individual administrations of ECT fell from 159,600 in 1980 to 
109,707 in 1989, and then to 65,928 in 1999. If the average number of administrations per 
course of treatment was six, this would mean that the number of people given ECT in 
England had fallen to about 18,000 in 1989, and 11,000 in 1999. Extrapolating from the last 
report by the Department of Health (2003), on the first quarter of 2002, produces an annual 
figure of 9,200 people. 
An ECT Accreditation Service (ECTAS) survey estimated that the number of people 
receiving ECT in England in 2006 had continued to fall, substantially, to about 1,300 
(Cresswell et al., 2007). A subsequent ECTAS report gathered responses from 78 of 104 ECT 
clinics in England and Wales, for 2012/2013 (Cresswell & Hodge, 2013). It can be estimated 
that in the 104 clinics 2,305 people received ECT, or 2,527 if one includes those receiving 
more than two courses during the year. Given that there were 71 English clinics reporting, it 
can be further estimated that about 2,385 of these courses occurred in England.  
  The current study can also provide only an estimate. The current number of N.H.S. 
mental health Trusts is 56. Multiplying the average number of annual ECT recipients for 29 
Trusts for the years 2011, 2013 and 2015 combined (50.40) by 56, produces a total of 2,822 
people, with totals for each year as follows: 2011- 2,728; 2013 – 3,045; 2015 - 2,675.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
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        A 2017 article in the Guardian newspaper, inaccurately headlined ‘Electroconvulsive 
therapy on the rise again in England’, reported on the responses of 44 of 56 English mental 
health Trusts to an FOI request (Davies & Duncan, 2017). The article reported that in those 
44 Trusts ‘more than 2,200’ people received ECT in 2015/2016 and that this was a rise from 
2012/2013. The actual numbers for each of the four years covered were: 2012/13 - 2070; 
2013/14 - 2229; 2014/15 - 2149; and 2015/16 - 2189 (personal communication, 2017). These 
variations are smaller than those found in the current study, which produced an increase of 
11.2% in ECT usage over two years followed by a decrease of 12.2% during the subsequent 
two years, with neither of those changes approaching significance. So the change over a three 
year period noted by the Guardian is actually part of the ‘considerable fluctuation over the 
last four years’ acknowledged in the same article. 
     Extrapolating from the 44 responding Trusts to all 56 Trusts produces estimates ranging 
from 2,635 to 2,837, and an average of 2,748 people per year for the period 2012/13 to 
2015/16. This is similar to the 2,822 figure produced by the current study. 
    Combining the current study with the  ECTAS reports for 2006 and 2012/2013 and the  
Guardian survey, it is reasonable to assume that the number of people in England receiving  
ECT annually within NHS Trusts had continued its steady decline until around 2006 (to a low  
of about 1,300), but then increased and stabilised for a few years at about double that number.  
It remained between 2,300 and 3,100 from 2011 to 2015/16. The latest ECTAS report, for 
2016/17, has just reported, however, a ‘decline from previous years’, to 2,135 (Buley, 
Copland & Hodge, 2017). The decline of 12.2% from 2013 to 2015 in the current survey, 
although not statistically significant by itself, is consistent with the ECTAS conclusion that, 
after a brief upturn, the forty year decline in the use of ECT in England has recommenced but 
has not yet reached the 2006 low point of 1,300.  
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Variation.  This large decline over several decades is matched by most other countries, but, as  
noted earlier, there is large variation between countries (Leikne et al., 2012). Huge regional 
variation within countries has also been mentioned in most reports for several decades. The 
1980 RCP survey found five-fold differences in usage between regions of Great Britain and 
17 fold differences between hospitals.  Variations are not reported by ECTAS. The current 
study, however, found a 12-fold difference per 100,000 between the highest and lowest 
Trusts. As the 1980 RCP report suggested, this is probably explained by the wide range of 
personal opinions about ECT held by individual psychiatrists. 
 
Gender and age 
The current study’s finding that women are twice as likely to receive ECT is remarkably 
consistent, in most countries, for decades (Leikne et al., 2012; Read et al., 2013). The 1981 
RCP report found that 69% of ECT recipients were women. The 2003 Department of Health 
figure was 70%, and the latest ECTAS survey reported 66% (Buley et al., 2017). These 
findings parallel the similar levels of disproportionate current prescribing of antidepressants 
and, before that, benzodiazepines, to women. The most recent ECTAS report found that the  
proportion is even higher for maintenance ECT - 74%. 
     The disproportionate use of ECT on older people, found in the current study, is also 
consistent with many other findings, internationally, over many decades (Leikne et al., 2012; 
Read et al., 2013).  In the 2012/2013 ECTAS survey, for instance, the average age was 62 
(Cresswell & Hedge, 2013). In the latest ECTAS report 59% were 60 or over, and 35% were 
70 or over (Buyley et al., 2017); with even higher proportions for maintenance ECT: 68% 60 
or over, 50% 70 or over. The mean age was 61 and the mean for maintenance ECT was 66. 
       If these findings about age and gender are partly or completely explained by higher 
levels of depression then one might wonder whether treatments that addressed the social 
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causes of the gender’s or age group’s greater distress might be deployed rather than 
treatments that are blind to such causal disparities. Poverty and loneliness come to mind as 
possible candidates.  
     The largest prospective study of cognitive dysfunction caused by ECT (Sackeim et al., 
2007), found that 12% met the criterion for ‘marked and persistent retrograde amnesia’, and 
that women and older people, the two groups who receive ECT disproportionately, had  
particularly high rates. The researchers pointed out women have a lower seizure threshold 
and electrical dosage was often not adjusted accordingly. The finding that older people are 
particularly susceptible to the cognitive dysfunction caused by administering electric shocks 
to the brain was not new (Sackeim, 2004), and is consistent with findings that they are also 
particularly susceptible to many of the adverse effects of antidepressant drugs (Coupland et 
al., 2011). This set of findings suggests that psychological therapies may be particularly 
appropriate for older people, and that it is particularly essential that they are not offered 
E.C.T. before being offered psychological therapy. 
 
Diagnosis 
The vast majority of diagnoses were depression (85%), which is broadly consistent with the 
most recent ECTAS report (90%). The ECTAS report, however, identified none of the 
diagnoses for which ECT is not recommended that were identified in the current study (in 
just over half the Trusts). This may be because of bias created by ECTAS using forced choice 
responses ‘based on NICE guidance’ (Buyley et al.). The use of ECT on people diagnosed 
with Personality Disorders, in six Trusts, is of concern. 
 
Consent 
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A substantial minority, 38%, is still being given ECT against their will. As with previous 
studies, there is enormous variation, from 0% to 100%. It appears the proportion given ECT 
without giving consent is rising (Buley et al., 2017). The proportion, including ‘emergencies’, 
was 18% in 1999 and 20% in 2002 (Department of Health, 1999, 2003).  ECTAS reported 
that in 2012/13 35% were detained under the Mental Health Act and deemed incapable of 
giving consent; by 2016/2017 this figure had risen to 41% 
It is of concern that six of the 20 Trusts that provided relevant information appeared to be 
in breach of section 58A of the Mental Health Act in that they were not using the correct 
combination of professionals to provide second opinions. The ECTAS reports do not monitor 
this. 
 
Efficacy 
The most commonly used method for assessing efficacy was the Clinical Global Impressions 
Scale. This very basic scale, which takes just a few seconds to complete, seems inadequate to 
assess an invasive and potentially dangerous intervention. Furthermore, there is no reason to 
believe that this inevitably subjective and simple approach to assessment was conducted by 
anyone other than the treating staff, who are necessarily potentially biased. There was no 
evidence, from any Trusts, of any attempt at independent assessments. There was also no 
evidence of any assessment of whether any gains perceived by the clinicians lasted beyond 
the end of treatment. The 13 Trusts that used validated scales are, however, to be 
commended. 
     That only four Trusts could provide any actual data, and that none could provide any 
follow-up data, is of serious concern. It suggests that most Trusts do not collate this data, and 
therefore are not able to review whether their use of ECT is effective. Perhaps they just 
assume it is helping. The rates of improvement attributed to ECT during treatment by three of 
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the four Trusts, or at least by their ECT clinicians, 80% - 90%, 95% - 100%, and 100%, were, 
when compared to the literature, incredible.  
The ‘Clinical Outcomes’ section of the latest ECTAS survey reports only CGI scores in 
(Buyley et al., 2017). It reports no data using validated measures or independent observers, 
and no data beyond the end of treatment.  
This pervasive failure to adequately assess the effectiveness of this controversial and 
intrusive intervention matches the failure of the psychiatric research community to do so. 
There has not been a single study of ECT compared to placebo for over thirty years, despite 
the fact that none of the ten that were conducted prior to 1986 found ECT to be any better 
than placebo beyond the end of treatment, and five found no benefit even during the 
treatment period (Read & Bentall, 2010; Read et al., 2013; Read & Arnold, 2017). The 
continued use of E.C.T., and the huge variation from one locality to another, relies on the 
genuinely held beliefs of the dwindling number of psychiatrist who use it rather than on any 
evidence of its effectiveness, for depression, psychosis or suicide prevention. The psycho-
social context within our mental health services that promotes the use of ECT as opposed to 
psychological treatments, regardless of the research evidence, includes an over reliance on an 
ideologically driven, simplistic ‘medical model’, supported by the profession of psychiatry 
(biological psychiatrists in particular) and the pharmaceutical industry (de Wattignar & Read, 
2009; Mosher, Gosden & Beder, 2013). This narrow, unbalanced approach is partly 
maintained, however, by the understandable human need to avoid listening to distressing and 
depressing experiences and feelings, and to the social causes thereof (Boyle, 2011; Read & 
Dillon, 2013; Speed, Moncrieff & Rapley, 2014).  
 
Adverse effects 
N.I.C.E.  guidelines (2017) state:  
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Cognitive function should be monitored on an ongoing basis, and at a minimum at the 
end of each course of treatment 
 
That eleven of 32 Trusts (34%) could not readily report what measures were in use to assess 
adverse effects is worrying. The 14 Trusts (44%) that reported using one or more validated 
scale are clearly taking their ethical responsibilities more seriously. Four Trusts (15%) even 
referred to assessment of adverse effects beyond the end of treatment, and are to be 
commended for doing so. 
     That only four Trusts could provide any actual data on adverse effects is particularly 
worrying. Overall when asked about adverse effects only two trusts out of 56 could provide 
any data about the best documented long term side effects of ECT, cognitive dysfunction and 
memory loss. The percentage of patients reported to be experiencing cognitive dysfunction 
by the only two Trusts providing relevant data ranged from 15% to 95%. No Trusts reported 
any follow up data on cognitive dysfunction after the end of treatment. These findings 
suggest that ECT clinicians and their managers are unaware of, or disinterested in, the 
memory dysfunction that follows almost every ECT treatment, at least temporarily, and 
which is ‘marked and persistent’ for at least one in eight (Sackeim et al., 2007) and probably 
far more (Breggin, 2008; Fosse & Read, 2009; Read et al., 2013; Rose et al., 2003, 2004). 
 
Recommendations 
A return to comprehensive national annual audits seems urgently needed. These should 
include attention to compliance with N.I.C.E. guidelines and mental health legislation.  In the 
meantime all mental health service providers must take responsibility for monitoring their 
own adherence to government guidelines and the law, and should familiarise themselves with 
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the research literature on the long term benefits and adverse effects of this controversial 
treatment. A multidisciplinary investigation into the ongoing excessive use of ECT on 
women and older people seems long overdue. 
 
Limitations 
           An obvious limitation is that data was received from only 32 Trusts, and that responses fell as  
low as four for data about actual outcomes - positive and negative. These latter response 
rates, however, constitute important findings in their own right, about whether Trusts are 
recording and collating the effects (however poorly measured) of such a controversial 
treatment. Previous surveys of Trusts about ECT, by ECTAS, produced higher response rates 
(see above), but our lower rate is partly mitigated by gathering data for each of three years, 
spanning five years.  
     The study generated no data from service providers other than NHS Trusts. It seems 
particularly problematic that some providers are operating beyond the jurisdiction of the FOI 
Act. This represents an uneven playing field for NHS providers and private organisations in 
relation to costs and accountability. 
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Table 1. ECT usage, demographics, consent and other monitoring of the 32 Trusts responding to  
Freedom of Information requests. 
 
 
National Health 
Service Trusts 
 
ECT per 
100,000 
 
% 
Female 
 
% 
Over 
60 
% 
Without 
consent 
% 
Offered 
Psych- 
ology 
Effectiveness 
 
Valid 
Measure   Data 
Adverse Effects 
 
Valid 
Measure   Data 
N Staffordshire 
Combined Healthcare 12.7 73.2 65.9   yes  yes  
Worcestershire 
Health & Care 12.4 65.9 60.1 46.2      
Cheshire & Wirral 
Partnership 12.2 68.9    yes  yes  
Surrey & Borders 
Partnership 9.7 67.1 40.5 15.3   yes no yes 
Leeds & York 
Partnership 9.1 64.8 71.4       
Nottinghamshire 
Healthcare 7.9  39.8   yes  yes  
Dorset Healthcare 
University 7.4  71.2 40.0  no  yes  
SW Yorkshire 
Partnership 6.6 68.2 47.0 40.9  yes  yes  
Leicestershire 
Partnership 6.6 68.0 52.8   yes   yes 
Northumberland, 
Tyne & Wear 6.5 70.8 55.8 40.5  yes  yes  
Cornwall 
Partnership 5.8 62.2 62.2  99.0 no yes   
Devon 
Partnership 5.5 64.2 65.5 34.5      
Coventry & 
Warwickshire 
Partnership 
5.5 50.9 53.3 29.7  yes yes yes yes 
Lancashire 
Care 4.9 65.9 60.1 46.2  no  yes  
Birmingham & Solihull 
Mental Health 4.3 56.1 73.5 59.4  no  no  
Humber 
 4.1 68.9 63.5  0     
Oxford Health 
 3.7 75.1 62.7 48.6      
Somerset 
Partnership 3.7 56.7 58.3       
Barnet, Enfield & 
Haringey Mental 
Health 
3.4 63.7 75.5 34.3  yes  no  
Greater Manchester 
West Mental Health 3.2 59.5 31.0 28.4 90.0 yes yes yes yes 
Hertfordshire 
Partnership University 3.0 66.7 50.0 72.2 100     
Bradford 
District 3.0 51.9 55.8 26.9 69.2 yes  yes  
Cambridgeshire & 
Peterborough 2.8   37.5  yes  yes  
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S Staffordshire & 
Shropshire Health 2.5 85.7 82.1  0 no  no  
S London & Maudsley 
 2.5   37.1      
Camden & Islington 
 2.3 66.7 22.2 60.0 100 no  no  
Kent & Medway NHS & 
Social Care Partnership 2.1 59.4 41.5 46.2 100 no  no  
West London Mental 
Health 2.0 72.1 39.5 51.2 100 yes  yes  
SW London & St 
George’s Mental 
Health 
1.2 48.8 41.5   no  no  
Black Country 
Partnership 1.0 70.8 50 100  yes    
Manchester Mental 
Health & Social Care a 67.8 50.8 44.1  no  yes  
Mersey Care Trust 
 b 67.2 64.8 35.2 82.0 no  yes  
          
                                           
Weighted Average %  66.1 56.5 38.7 72.6     
 
a = Trust now subsumed into Greater Manchester West MHT; population data not available.  
 
b = reliable population data not available.  
 
Empty cell = no response/ data not available.  
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